Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Morphosys AG reaffirms FY 2014 guidance - Conference Call


Tuesday, 29 Apr 2014 08:00am EDT 

Morphosys AG:Reconfirms financial guidance for FY 2014.Anticipates FY 2014 total growth revenues between 58 million euros and 63 million euros.Anticipates FY 2014 negative EBIT of between minus 11 million euros and minus 16 million euros.FY 2014 revenue of 62 million euros and EBIT of (16) million euros - Thomson Reuters I/B/E/S. 

Company Quote

72.29
1.89 +2.68%
11:29am EDT